• Ansell, S.M., Habermann, T.M., Kurtin, P.J., Witzig, T.E., Chen, M.G., Li, C.Y., Inwards, D.J. & Colgan, J.P. (1997) Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. Journal of Clinical Oncology, 15, 22962301.
  • Ascani, S., Zinzani, P.L., Gherlinzoni, F., Sabattini, E., Briskomatis, A., de Vivo, A., Piccioli, M., Fraternali, O.G., Pieri, F., Goldoni, A., Piccaluga, P.P., Zallocco, D., Burnelli, R., Leoncini, L., Falini, B., Tura, S. & Pileri, S.A. (1997) Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification. Annals of Oncology, 8, 583592.
  • Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W. & Tubiana, M. (1971) Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Research, 31, 18601861.
  • Enblad, G., Hagberg, H., Erlanson, M., Lundin, J., MacDonald, A.P., Repp, R., Schetelig, J., Seipelt, G. & Osterborg, A. (2004) A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas. Blood, 103, 29202924.
  • Gallamini, A., Stelitano, C., Calvi, R., Bellei, M., Mattei, D., Vitolo, U., Morabito, F., Martelli, M., Brusamolino, E., Iannitto, E., Zaja, F., Cortelazzo, S., Rigacci, L., Devizzi, L., Todeschini, G., Santini, G., Brugiatelli, M. & Federico, M. (2004) Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood, 103, 24742479.
  • Gascoyne, R.D., Aoun, P., Wu, D., Chhanabhai, M., Skinnider, B.F., Greiner, T.C., Morris, S.W., Connors, J.M., Vose, J.M., Viswanatha, D.S., Coldman, A. & Weisenburger, D.D. (1999) Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood, 93, 39133921.
  • Gisselbrecht, C., Gaulard, P., Lepage, E., Coiffier, B., Briere, J., Haioun, C., Cazals-Hatem, D., Bosly, A., Xerri, L., Tilly, H., Berger, F., Bouhabdallah, R. & Diebold, J. (1998) Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood, 92, 7682.
  • Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., Wolf-Peeters, C., Falini, B. & Gatter, K.C. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 13611392.
  • Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. & Bloomfield, C.D. (2000) The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology, 36, 6986.
  • Hoelzer, D., Gokbuget, N., Digel, W., Faak, T., Kneba, M., Reutzel, R., Romejko-Jarosinska, J., Zwolinski, J. & Walewski, J. (2002) Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood, 99, 43794385.
  • Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J.W. (2001) World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.
  • Lenihan, D.J., Alencar, A.J., Yang, D., Kurzrock, R., Keating, M.J. & Duvic, M. (2004) Cardiac toxicity of alemtuzumab in patients with mycosis fungoides/Sezary syndrome. Blood, 104, 655658.
  • Lopez-Guillermo, A., Cid, J., Salar, A., Lopez, A., Montalban, C., Castrillo, J.M., Gonzalez, M., Ribera, J.M., Brunet, S., Garcia-Conde, J., Fernandez, D.S., Bosch, F. & Montserrat, E. (1998) Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification. Annals of Oncology, 9, 849855.
  • Morris, E., Thomson, K., Craddock, C., Mahendra, P., Milligan, D., Cook, G., Smith, G.M., Parker, A., Schey, S., Chopra, R., Hatton, C., Tighe, J., Hunter, A., Peggs, K., Linch, D., Goldstone, A. & Mackinnon, S. (2004) Outcome following Alemtuzumab (CAMPATH-1H) -containing reduced intensity allogeneic transplant regimen for relapsed and refractory non-Hodgkin's lymphoma (NHL). Blood, 104, 38653871.
  • Pellatt, J., Sweetenham, J., Pickering, R.M., Brown, L. & Wilkins, B. (2002) A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphoma. Annals of Hematology, 81, 267272.
  • Pfreundschuh, M.G., Rueffer, U., Lathan, B., Schmitz, N., Brosteanu, O., Hasenclever, D., Haas, R., Kirchner, H., Koch, P. & Kuse, R. (1994) Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group. Journal of Clinical Oncology, 12, 580586.
  • Reimer, P., Schertlin, T., Rudiger, T., Geissinger, E., Roth, S., Kunzmann, V., Weissinger, F., Nerl, C., Schmitz, N., Muller-Hermelink, H.K. & Wilhelm, M. (2004) Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of a prospective multicenter study. Hematology Journal, 5, 304311.
  • Reiser, M., Josting, A., Soltani, M., Staib, P., Salzberger, B., Diehl, V. & Engert, A. (2002) T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors. Leukemia and Lymphoma, 43, 805811.
  • Rodriguez, J., Munsell, M., Yazji, S., Hagemeister, F.B., Younes, A., Andersson, B., Giralt, S., Gajewski, J., de Lima, M., Couriel, D., Romaguera, J., Cabanillas, F.F., Champlin, R.E. & Khouri, I.F. (2001) Impact of high-dose chemotherapy on peripheral T-cell lymphomas. Journal of Clinical Oncology, 19, 37663770.
  • Rudiger, T., Weisenburger, D.D., Anderson, J.R., Armitage, J.O., Diebold, J., MacLennan, K.A., Nathwani, B.N., Ullrich, F. & Muller-Hermelink, H.K. (2002) Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Annals of Oncology, 13, 140149.
  • Song, K.W., Mollee, P., Keating, A. & Crump, M. (2003) Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype. British Journal of Haematology, 120, 978985.
  • Stansfeld, A.G., Diebold, J., Noel, H., Kapanci, Y., Rilke, F., Kelenyi, G., Sundstrom, C., Lennert, K., van Unnik, J.A. & Mioduszewska, O. (1988) Updated Kiel classification for lymphomas. Lancet, 1, 292293.
  • The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. New England Journal of Medicine, 329, 987994.
  • The Non-Hodgkin's Lymphoma Classification Project (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood, 89, 39093918.
  • Tilly, H., Gaulard, P., Lepage, E., Dumontet, C., Diebold, J., Plantier, I., Berger, F., Symann, M., Petrella, T., Lederlin, P. & Briere, J. (1997) Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood, 90, 37273734.